IP Library › Granted Patent US 9,561,202
Granted Patent B2
US 9,561,202 · App. 14/671,579 · Granted Feb 7, 2017

Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field

Inventors: Giancarlo Naccari (Monza, IT); Sergio Baroni (Villa D'adda, IT)
Assignee: Nogra Pharma Limited
A61K31/196C07C229/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,561,202
App. No.
14/671,579
Granted
Feb 7, 2017
Kind
B2
Abstract

The present invention relates to compounds comprising the general formula (I), in which R 1 and R 2 , which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.

Claims (13)

1. A method of treating a colon cancer, comprising administering to a mammal in need thereof a compound represented by the general formula (I)

in which

R 1 and R 2 , which may be identical or different, are selected from the group consisting of —H or a linear or branched alkyl group having from 1 to 6 carbon atoms;

Y is selected from the group consisting of —H, —OH, —OR 3 , or —COOH wherein R 3 is selected from the group consisting of phenyl, benzyl, —CF 3 , —CF 2 CF 3 , vinyl, allyl, and a linear or branched alkyl group having from 1 to 6 carbon atoms;

Z is selected from the group consisting of —OR 3 , and —CH(OR 3 )COOH, in which R 3 is selected from the group consisting of H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms; or salts thereof.

2. The method of claim 1 , wherein the mammal is a human.

3. The method of claim 1 , wherein Y is H.

4. The method of claim 1 , wherein Z is —CH(OR 3 )COOH, wherein R 3 is selected from the group consisting of —CH 3 or —CH 2 CH 3 .

5. The method of claim 1 , wherein the compound is selected from the group consisting of:

6. The method of claim 5 , wherein the compound is

7. The method of claim 1 , wherein the compound is (R)-2-methoxy-3-(4′-aminophenyl)propionic acid.

8. The method of claim 1 , wherein the compound is (S)-2-methoxy-3-(4′-aminophenyl)propionic acid.

9. The method of claim 1 , wherein the compound is selected from the group consisting of: ±-2-hydroxy-2-(3′-aminophenyl)acetic acid, ±-2-hydroxy-2-(4′-aminophenyl)acetic acid, ±-2-hydroxy-3-(4′-aminophenyl)propionic acid, ±-2-methoxy-3-(3′-aminophenyl)propionic acid and ±-2-methoxy-3-(4′-aminophenyl)propionic acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2016
From: NACCARI, GIANCARLO; BARONI, SERGIO
To: GIULIANI INTERNATIONAL LIMITED
Reel/Frame 038659/0857 →
CHANGE OF NAME Recorded May 20, 2016
From: GIULIANI INTERNATIONAL LIMITED
To: NOGRA PHARMA LIMITED
Reel/Frame 038771/0928 →
Priority Claims (1)
IT RM2005A0389 · Jul 22, 2005 · national
Continuity (4)
Division 14202386 · Mar 10, 2014
Continuation 13408439 · Feb 29, 2012
Division 11989090
Related Publication 20150265562A1 · Sep 24, 2015